Jan Bogaerts, Methodology Vice Director at EORTC HQ, discusses clinical trial design for rare cancers with Helen Saul
10 Feb 2015
Hear Jan Bogaerts (photo), EORTC Methodology Vice Director, discuss “Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative”, an article published in European Journal of Cancer (2015) 51, 271-281.
Related News
EORTC participation at ISPOR Europe 2025 conference
7 Nov 2025
EORTC Quality of Life Group participating at the ISOQOL 2025 Conference
22 Oct 2025
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025
EORTC celebrates the 100th anniversary of p-value on World Statistics Day
20 Oct 2025
EORTC Announces Final Overall Survival Results from the PEACE-3 Trial
19 Oct 2025
Results from EORTC trial define new standard of care for aggressive brain tumours
18 Oct 2025
EORTC’s presence at ESMO 2025
17 Oct 2025
EORTC’s presence at EANO 2025
16 Oct 2025
EORTC celebrates Pink October: shaping the future of breast cancer care
15 Oct 2025
EORTC shines a light on advancements in radioligand therapy
8 Oct 2025
